Dyne Therapeutics Appoints Doug Kerr as Chief Medical Officer and Johanna Friedl-Naderer as Chief Commercial Officer
Position
Chief Commercial Officer
Company
Dyne Therapeutics
WalthamBiotechnologyHealth CareTherapeuticsDescription
Dyne Therapeutics has announced the appointment of Doug Kerr as chief medical officer, succeeding Wildon Farwell, and Johanna Friedl-Naderer as chief commercial officer. Additionally, Lucia Celona has been appointed as chief human resources officer.
Quick answer
Dyne Therapeutics Appoints Doug Kerr as Chief Medical Officer and Johanna Friedl-Naderer as Chief Commercial Officer (September 3, 2024). Dyne Therapeutics is based in Waltham, Massachusetts, United States.
- Who is the new Chief Commercial Officer at Dyne Therapeutics?
- Dyne Therapeutics named Johanna Friedl-Naderer Chief Commercial Officer, announced September 3, 2024.
- What did Dyne Therapeutics announce on September 3, 2024?
- Dyne Therapeutics has announced the appointment of Doug Kerr as chief medical officer, succeeding Wildon Farwell, and Johanna Friedl-Naderer as chief commercial officer. Additionally, Lucia Celona has been appointed as chief human resources officer.
- What does Dyne Therapeutics do?
- Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases.
- Where is Dyne Therapeutics based?
- Dyne Therapeutics is based in Waltham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Forward Therapeutics (September 3, 2024), Infinimmune (September 3, 2024), Novocure (September 3, 2024) and Amphista Therapeutics (September 3, 2024) also announced leadership changes within 45 days of Dyne Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Forward Therapeutics Appoints Ulrich Thienel, M.D., Ph.D. as Chief Medical Officer (September 3, 2024)
- Infinimmune Appoints Tim Sullivan, Ph.D., as Chief Business Officer (September 3, 2024)
- Novocure CEO Asaf Danziger to Retire, CFO Ashley Cordova to Succeed (September 3, 2024)
- Amphista Therapeutics Appoints Antony Mattessich as Chief Executive Officer (September 3, 2024)
- Affimed Appoints Shawn M. Leland as Chief Executive Officer (September 3, 2024)
- Belite Bio, Inc Appoints Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer (September 1, 2024)
Who to call at Dyne Therapeutics, and when
A new leader at Dyne Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Dyne Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dyne Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dyne Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Dyne Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Dyne Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.